Developer docs
API playgroundTry for free, no card

Search company profiles

Amai Proteins

Full company profile

uuid00021ev

Namestring
Amai Proteins
Legal namestring
Amai Proteins
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Amai Proteins is a Rehovot, Israel-based food technology company that develops and produces designer sweet proteins as functional ingredients for food and beverage manufacturers. Its flagship product, sweelin®, is a monellin-based sweet protein inspired by the serendipity berry, produced via precision fermentation using the same yeast strain employed for the Impossible Burger's heme ingredient. sweelin® is approximately 3,000 times sweeter than sugar on a weight-to-weight basis and is positioned to enable 40-70% sugar reduction across applications including soft drinks, fruit juices, dairy, sauces, chocolate, confectionery, and dietary supplements, without compromising taste, cost, or clean-label positioning ('Serendipity Berry Sweet Protein'). The company has published the world's first human clinical trial data on sweet proteins, confirming no impact on blood glucose, insulin, or GLP-1 levels.

The company's core technology is the Pro3 Platform, which combines AI Computational Protein Design (AI-CPD) with precision fermentation and food technology to engineer proteins optimized for taste, manufacturability, and food compatibility. Amai holds granted patents on both the Pro3 Platform and sweelin® production methods, and trades on its regulatory achievements — FDA GRAS approval in February 2026 and Singapore Food Agency approval in May 2026 — as the first precision fermentation-derived sweet protein to receive these clearances, opening U.S. and APAC commercial markets.

Amai operates a B2B enterprise sales model, selling sweelin® as an ingredient on quote-based, annual-billing supply agreements to large CPG and food manufacturers. Commercial validation to date is anchored by named partnerships with Ocean Spray (first protein-sweetened reduced-sugar cranberry juice, December 2020) and the EIT Food 'Sugar-out, Prot-In' consortium with PepsiCo and Danone (September 2019). The company has raised approximately $22.8 million across disclosed rounds from 2017 through 2022, with investors including iAngels, Welltech Ventures, Zora Ventures, BayWa Venture, SGInnovate, and the Israel Innovation Authority, and is led by CEO Amir Guttman following the founder-led era of Dr. Ilan Samish.

Short descriptiontext

Amai Proteins is an Israel-based food technology company that produces sweelin®, a precision-fermented sweet protein ingredient for food and beverage manufacturers, enabling 40-70% sugar reduction with FDA GRAS and Singapore regulatory approval.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRehovot, Israel
HQ citystring
Rehovot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sweet protein ingredients, precision fermentation, sugar reduction, food technology platform, designer proteins
Industry4 codes
PRIMARYAFAJAAAH
Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin)
Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)
SECONDARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYAFAJADAH
Sweetness Modulators & Enhancers (Sweetness Boosters, Temporal Modifiers)
Agriculture & Food Production/Food Ingredients & Additives/Flavors & Flavor Enhancers (Natural/Artificial Flavors, Umami Enhancers)
SECONDARYAFAJAAAO
Sweetener Blends & Systems (Bulk + HIS Blends, Customized Sweetening Systems)
Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)
NAICS code2 codes
  • Flavoring Syrup and Concentrate Manufacturing311930
  • Food Manufacturing311
SIC code2 codes
  • Miscellaneous Food Preparations & Kindred Products2090
  • Food And Kindred Products2000
Product category
Food Ingredients
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Ingredient Sales to Food & Beverage Manufacturers
TypeSubscription Recurring
Description

Amai Proteins sells sweelin® as an ingredient to food and beverage companies for use in their products. The company enables significant sugar reduction (40-70%) in customer formulations without compromising taste, health, cost, or sustainability.

amaiproteins.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
Pricing details1 tier
1B2B ingredient pricing for food and beverage manufacturers
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing not publicly disclosed; quote-based B2B sales model for ingredient supply agreements.

amaiproteins.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1sweelin®
Description

Flaghip hyper-sweet protein product derived from serendipity berry, approximately 3,000 times sweeter than sugar, produced via precision fermentation. Enables up to 70% sugar reduction in food and beverages.

amaiproteins.com
+1 more record
Core offering1 text field

Amai Proteins develops and produces sweelin®, a hyper-sweet protein ingredient (~3,000× sweeter than sugar) derived from the serendipity berry and manufactured via precision fermentation using its proprietary Pro3 Platform (AI Computational Protein Design + Precision Fermentation + Food Technology). The ingredient is sold to food and beverage manufacturers as a drop-in sugar-reduction solution, enabling 40–70% sugar replacement across beverages, dairy, confectionery, condiments, and supplements without compromising taste, health, cost, or sustainability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 40-70% sugar reduction in food and beverages
+4 more records
Product overview1 text field

Amai Proteins is a food technology company that operates a platform-plus-products model. The company developed sweelin®, a hyper-sweet protein ingredient produced via its proprietary Pro3 Platform technology, which combines AI Computational Protein Design with Precision Fermentation. sweelin® serves as a functional ingredient for food and beverage manufacturers to reduce sugar content by 40-70% while maintaining taste and functionality.

Product and service1 record
1sweelin® Sweet Protein
CategorySweet Protein Ingredient
Description

A hyper-sweet protein ingredient derived from the serendipity berry and produced via precision fermentation; approximately 3,000× sweeter than sugar weight-to-weight. Sold to food and beverage manufacturers to enable 40–70% sugar reduction across beverages, chocolate, condiments, confectionery, chewing gum, and dietary supplements without compromising taste, health, cost, or sustainability. Labeled as 'Serendipity Berry Sweet Protein' for clean-label positioning.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Ocean Spray
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-12-04
Description

Ocean Spray partnered with Amai Proteins to create the first protein-sweetened reduced sugar cranberry juice. The new beverage aims to feature approximately 40% less sugar while maintaining the classic taste of Ocean Spray cranberry products. This partnership represents early commercial validation of sweelin® in real product applications.

amaiproteins.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-07-01
Description

SodaStream's syrup R&D department conducted initial testing of Amai's sweet proteins for potential incorporation into their beverage products. The collaboration explored whether sweelin® could work with SodaStream's product profile and taste requirements.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-09-27
Description

PepsiCo joined the 'Sugar-out, Prot-In' consortium with Amai Proteins, Danone, and the Technion Institute of Technology as part of an EIT Food initiative to develop sugar reduction solutions for food products. The consortium aims to address the global sugar overconsumption problem through innovative protein-based sweeteners.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-09-27
Description

Danone partnered in the 'Sugar-out, Prot-In' consortium focused on developing sugar reduction solutions through sweet proteins. As part of the Sugar & Sweetness acceleration project, Danone is working with Amai to explore how sweet proteins can be incorporated into dairy and functional food products.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-09-27
Description

The Technion Institute of Technology serves as the academic research partner in the 'Sugar-out, Prot-In' consortium, providing scientific expertise in protein design and fermentation technology for the development of sweet proteins.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bonumose produces rare sugars (e.g., tagatose, allulose) via proprietary enzymatic/fermentation processes as lower-calorie, low-glycemic sweeteners for food and beverage manufacturers. It is the most direct competitor to Amai in the alternative-sweetener-for-sugar-reduction category, addressing the same CPG customers with a similar B2B ingredient model.

TypeDirect peer
Description

Manus Bio develops specialty ingredients through advanced fermentation, including natural flavor and sweetener ingredients. It is directly comparable to Amai in combining AI/systems biology with precision fermentation to produce food-grade ingredients for CPG customers.

TypeDirect peer
Description

Amyris used precision fermentation to produce ingredients such as sugarcane-derived sugar (Reb M) and other food-grade ingredients. Despite its recent restructuring, it is a direct comparable for the precision-fermentation sweetener ingredient model Amai is pursuing.

TypeDirect peer
Description

The EVERY Company uses precision fermentation to produce animal-free proteins (ovalbumin, etc.) for food and beverage manufacturers. It is directly comparable to Amai in applying precision fermentation to food ingredients and selling B2B to CPGs, though on a different end-application.

TypeDirect peer
Description

Perfect Day uses precision fermentation to produce animal-free whey and casein proteins for food and beverage companies. It shares Amai's core precision-fermentation protein platform technology and B2B CPG ingredient business model, though targeting dairy proteins rather than sweeteners.

TypeDirect peer
Description

Geltor produces animal-free functional proteins (e.g., collagen, elastin) via precision fermentation for CPG customers. Comparable to Amai as a precision-fermentation protein producer for food/beauty ingredients serving large consumer brands.

TypeEmerging player
Description

MycoTechnology uses fermentation (mycelial and otherwise) to develop food ingredients including sweetness-modulation and taste-masking solutions for CPG customers. Comparable as a fermentation-derived food ingredient supplier addressing sugar reduction and taste challenges.

TypeBroad incumbent
Description

Cargill, through EverSweet (with DSM) and its broader sweetener and ingredient portfolio, is a major incumbent supplier of stevia- and fermentation-derived sweeteners to CPGs. It is a broad incumbent that overlaps with Amai in fermentation-derived sweeteners but operates at much larger scale and across many categories.

TypeBroad incumbent
Description

Ingredion, which acquired PureCircle, is one of the largest suppliers of stevia-based sweeteners and other sugar-reduction ingredients to global CPGs. It is a broad incumbent competitor to Amai in the natural high-intensity sweetener category.

TypeBroad incumbent
Description

DSM-Firmenich is a global leader in food ingredients, flavors, and sweeteners, including fermentation-derived stevia (with Cargill via Avansya). Comparable as a broad incumbent offering fermentation-derived sweeteners and taste solutions to the same CPG customer base Amai targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Amai Proteins

Food Ingredientsamaiproteins.com

Amai Proteins is an Israel-based food technology company that produces sweelin®, a precision-fermented sweet protein ingredient for food and beverage manufacturers, enabling 40-70% sugar reduction with FDA GRAS and Singapore regulatory approval.

What Amai Proteins does

Amai Proteins is a Rehovot, Israel-based food technology company that develops and produces designer sweet proteins as functional ingredients for food and beverage manufacturers. Its flagship product, sweelin®, is a monellin-based sweet protein inspired by the serendipity berry, produced via precision fermentation using the same yeast strain employed for the Impossible Burger's heme ingredient. sweelin® is approximately 3,000 times sweeter than sugar on a weight-to-weight basis and is positioned to enable 40-70% sugar reduction across applications including soft drinks, fruit juices, dairy, sauces, chocolate, confectionery, and dietary supplements, without compromising taste, cost, or clean-label positioning ('Serendipity Berry Sweet Protein'). The company has published the world's first human clinical trial data on sweet proteins, confirming no impact on blood glucose, insulin, or GLP-1 levels.

The company's core technology is the Pro3 Platform, which combines AI Computational Protein Design (AI-CPD) with precision fermentation and food technology to engineer proteins optimized for taste, manufacturability, and food compatibility. Amai holds granted patents on both the Pro3 Platform and sweelin® production methods, and trades on its regulatory achievements — FDA GRAS approval in February 2026 and Singapore Food Agency approval in May 2026 — as the first precision fermentation-derived sweet protein to receive these clearances, opening U.S. and APAC commercial markets.

Amai operates a B2B enterprise sales model, selling sweelin® as an ingredient on quote-based, annual-billing supply agreements to large CPG and food manufacturers. Commercial validation to date is anchored by named partnerships with Ocean Spray (first protein-sweetened reduced-sugar cranberry juice, December 2020) and the EIT Food 'Sugar-out, Prot-In' consortium with PepsiCo and Danone (September 2019). The company has raised approximately $22.8 million across disclosed rounds from 2017 through 2022, with investors including iAngels, Welltech Ventures, Zora Ventures, BayWa Venture, SGInnovate, and the Israel Innovation Authority, and is led by CEO Amir Guttman following the founder-led era of Dr. Ilan Samish.

Amai Proteins firmographics

Firmographics
Name
Amai Proteins
Legal name
Amai Proteins
Website
https://amaiproteins.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Amai Proteins is an Israel-based food technology company that produces sweelin®, a precision-fermented sweet protein ingredient for food and beverage manufacturers, enabling 40-70% sugar reduction with FDA GRAS and Singapore regulatory approval.
Ownership category
akta.pro rank

Amai Proteins industry classification

Industry
Product category
Food Ingredients
NAICS
Flavoring Syrup and Concentrate Manufacturing (311930), Food Manufacturing (311)
SIC
Miscellaneous Food Preparations & Kindred Products (2090), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAJAAAH
Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin)
Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)
SECONDARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYAFAJADAH
Sweetness Modulators & Enhancers (Sweetness Boosters, Temporal Modifiers)
Agriculture & Food Production/Food Ingredients & Additives/Flavors & Flavor Enhancers (Natural/Artificial Flavors, Umami Enhancers)
SECONDARYAFAJAAAO
Sweetener Blends & Systems (Bulk + HIS Blends, Customized Sweetening Systems)
Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)

Keywords

  • Sweet protein ingredients
  • Precision fermentation
  • Sugar reduction
  • Food technology platform
  • Designer proteins

Where Amai Proteins is headquartered

Location

Headquarters

HQ city
Rehovot
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Amai Proteins business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. Ingredient Sales to Food & Beverage Manufacturers: Amai Proteins sells sweelin® as an ingredient to food and beverage companies for use in their products. The company enables significant sugar reduction (40-70%) in customer formulations without compromising taste, health, cost, or sustainability.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualB2B ingredient pricing for food and beverage manufacturers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Amai Proteins product offering

Product offering

Core offering

Amai Proteins develops and produces sweelin®, a hyper-sweet protein ingredient (~3,000× sweeter than sugar) derived from the serendipity berry and manufactured via precision fermentation using its proprietary Pro3 Platform (AI Computational Protein Design + Precision Fermentation + Food Technology). The ingredient is sold to food and beverage manufacturers as a drop-in sugar-reduction solution, enabling 40–70% sugar replacement across beverages, dairy, confectionery, condiments, and supplements without compromising taste, health, cost, or sustainability.

Product overview

Amai Proteins is a food technology company that operates a platform-plus-products model. The company developed sweelin®, a hyper-sweet protein ingredient produced via its proprietary Pro3 Platform technology, which combines AI Computational Protein Design with Precision Fermentation. sweelin® serves as a functional ingredient for food and beverage manufacturers to reduce sugar content by 40-70% while maintaining taste and functionality.

Differentiator

Problem solved

Functional benefit

Brands

  • sweelin®: Flaghip hyper-sweet protein product derived from serendipity berry, approximately 3,000 times sweeter than sugar, produced via precision fermentation. Enables up to 70% sugar reduction in food and beverages.
  • Pro3 Platform

Products and services

  • sweelin® Sweet Protein A hyper-sweet protein ingredient derived from the serendipity berry and produced via precision fermentation; approximately 3,000× sweeter than sugar weight-to-weight. Sold to food and beverage manufacturers to enable 40–70% sugar reduction across beverages, chocolate, condiments, confectionery, chewing gum, and dietary supplements without compromising taste, health, cost, or sustainability. Labeled as 'Serendipity Berry Sweet Protein' for clean-label positioning.

Quantifiable outcome

  • 40-70% sugar reduction in food and beverages
  • +4 more outcomes

Companies that use Amai Proteins

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Amai Proteins technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Amai Proteins partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, minor and major.

  • Ocean SpraycoreStrategic or Co-development Partner · 4 December 2020Ocean Spray partnered with Amai Proteins to create the first protein-sweetened reduced sugar cranberry juice. The new beverage aims to feature approximately 40% less sugar while maintaining the classic taste of Ocean Spray cranberry products. This partnership represents early commercial validation of sweelin® in real product applications.
  • SodaStreamminorStrategic or Co-development Partner · 1 July 2020SodaStream's syrup R&D department conducted initial testing of Amai's sweet proteins for potential incorporation into their beverage products. The collaboration explored whether sweelin® could work with SodaStream's product profile and taste requirements.
  • PepsiCocoreStrategic or Co-development Partner · 27 September 2019PepsiCo joined the 'Sugar-out, Prot-In' consortium with Amai Proteins, Danone, and the Technion Institute of Technology as part of an EIT Food initiative to develop sugar reduction solutions for food products. The consortium aims to address the global sugar overconsumption problem through innovative protein-based sweeteners.
  • DanonecoreStrategic or Co-development Partner · 27 September 2019Danone partnered in the 'Sugar-out, Prot-In' consortium focused on developing sugar reduction solutions through sweet proteins. As part of the Sugar & Sweetness acceleration project, Danone is working with Amai to explore how sweet proteins can be incorporated into dairy and functional food products.
  • Technion Institute of TechnologymajorStrategic or Co-development Partner · 27 September 2019The Technion Institute of Technology serves as the academic research partner in the 'Sugar-out, Prot-In' consortium, providing scientific expertise in protein design and fermentation technology for the development of sweet proteins.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Amai Proteins competitors and assessment

Company assessment

Direct peers

  • Bonumose: Bonumose produces rare sugars (e.g., tagatose, allulose) via proprietary enzymatic/fermentation processes as lower-calorie, low-glycemic sweeteners for food and beverage manufacturers. It is the most direct competitor to Amai in the alternative-sweetener-for-sugar-reduction category, addressing the same CPG customers with a similar B2B ingredient model.
  • Manus Bio: Manus Bio develops specialty ingredients through advanced fermentation, including natural flavor and sweetener ingredients. It is directly comparable to Amai in combining AI/systems biology with precision fermentation to produce food-grade ingredients for CPG customers.
  • Amyris: Amyris used precision fermentation to produce ingredients such as sugarcane-derived sugar (Reb M) and other food-grade ingredients. Despite its recent restructuring, it is a direct comparable for the precision-fermentation sweetener ingredient model Amai is pursuing.
  • The EVERY Company (formerly Clara Foods): The EVERY Company uses precision fermentation to produce animal-free proteins (ovalbumin, etc.) for food and beverage manufacturers. It is directly comparable to Amai in applying precision fermentation to food ingredients and selling B2B to CPGs, though on a different end-application.
  • Perfect Day: Perfect Day uses precision fermentation to produce animal-free whey and casein proteins for food and beverage companies. It shares Amai's core precision-fermentation protein platform technology and B2B CPG ingredient business model, though targeting dairy proteins rather than sweeteners.
  • Geltor: Geltor produces animal-free functional proteins (e.g., collagen, elastin) via precision fermentation for CPG customers. Comparable to Amai as a precision-fermentation protein producer for food/beauty ingredients serving large consumer brands.

Emerging players

  • MycoTechnology: MycoTechnology uses fermentation (mycelial and otherwise) to develop food ingredients including sweetness-modulation and taste-masking solutions for CPG customers. Comparable as a fermentation-derived food ingredient supplier addressing sugar reduction and taste challenges.

Broad incumbents

  • Cargill (EverSweet / sweetener portfolio): Cargill, through EverSweet (with DSM) and its broader sweetener and ingredient portfolio, is a major incumbent supplier of stevia- and fermentation-derived sweeteners to CPGs. It is a broad incumbent that overlaps with Amai in fermentation-derived sweeteners but operates at much larger scale and across many categories.
  • Ingredion (PureCircle / stevia portfolio): Ingredion, which acquired PureCircle, is one of the largest suppliers of stevia-based sweeteners and other sugar-reduction ingredients to global CPGs. It is a broad incumbent competitor to Amai in the natural high-intensity sweetener category.
  • DSM-Firmenich: DSM-Firmenich is a global leader in food ingredients, flavors, and sweeteners, including fermentation-derived stevia (with Cargill via Avansya). Comparable as a broad incumbent offering fermentation-derived sweeteners and taste solutions to the same CPG customer base Amai targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Amai Proteins social profiles

Digital presence

Amai Proteins compliance and trust

Trust signal

Compliance2 records

Amai Proteins financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Amai Proteins leadership team

Management profile

Number of profiles

Profiles5 records

Amai Proteins funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Amai Proteins M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amai Proteins

What does Amai Proteins do?

Amai Proteins develops and produces sweelin®, a hyper-sweet protein ingredient (~3,000× sweeter than sugar) derived from the serendipity berry and manufactured via precision fermentation using its proprietary Pro3 Platform (AI Computational Protein Design + Precision Fermentation + Food Technology). The ingredient is sold to food and beverage manufacturers as a drop-in sugar-reduction solution, enabling 40–70% sugar replacement across beverages, dairy, confectionery, condiments, and supplements without compromising taste, health, cost, or sustainability.

Is Amai Proteins a public or private company?

Amai Proteins is a private company. It is classified as venture growth investor backed and is currently operating.

When was Amai Proteins founded?

Amai Proteins was founded in 2018. It employs 11 to 50 people.

Where is Amai Proteins based?

Amai Proteins is headquartered in Rehovot, Israel, in the Middle East region.

How does Amai Proteins make money?

One revenue line is on record: ingredient Sales to Food & Beverage Manufacturers.

Who are Amai Proteins's main competitors?

Direct peers on record are Bonumose, Manus Bio, Amyris, The EVERY Company (formerly Clara Foods), Perfect Day and Geltor. MycoTechnology is listed as an emerging player. Broad incumbents are Cargill (EverSweet / sweetener portfolio), Ingredion (PureCircle / stevia portfolio) and DSM-Firmenich.

Does Amai Proteins have an API?

No public API is recorded for Amai Proteins.

What industry is Amai Proteins in?

Amai Proteins's product category is Food Ingredients. Its primary akta.pro industry code is AFAJAAAH, Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin), with a secondary code of AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation). Its NAICS code is 311930 and its SIC code is 2090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Food Business NewsAmai Proteins welcomes new CEOAmai Proteins named Doug Brown as its new CEO, succeeding Amir Guttman, who is transitioning to an executive board member role. Brown joins from Sirio Pharma, where he was vice president of global account management. Amai's flagship product is sweelin, a monellin-based sweet protein produced via precision fermentation.Third NewsDoug Brown Takes the Helm as CEO of Amai Proteins to Drive Innovation in Sweet Protein SectorDoug Brown will become CEO of Amai Proteins on September 1, 2026, to drive growth of its sweet protein product sweelin®. The protein is 3,000 times sweeter than sugar and enables up to 70% sugar reduction. The company aims to capture the health-conscious market.PR NewswireDoug Brown, global nutrition industry veteran, appointed as new CEO Amai ProteinsAmai Proteins appointed Doug Brown as CEO, effective September 1, 2026. The Israeli food-tech startup's lead product, sweelin®, is a monellin-based sweet protein 3,000 times sweeter than sugar, enabling up to 70% sugar reduction. Brown previously served as CCO for Clasado Biosciences and Head of Business Development for Nutritional Lipids at DSM.PR NewswireAmai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage ProductsThe Israeli Ministry of Health approved sweelin® as a novel food ingredient, enabling food and beverage manufacturers to commercialize products sweetened with it. The approval follows US FDA GRAS and Singapore SFA clearances, making Israel the third market to authorize the ingredient in under six months. The company is now working with manufacturers to commercialize sweelin® products.PR NewswireAmai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage ProductsThe Israeli Ministry of Health approved sweelin® as a novel food ingredient, enabling food and beverage manufacturers to commercialize products sweetened with it. The approval follows clearances in the US and Singapore, and authorizes use in over 25 food and beverage categories. Amai Proteins is working with manufacturers to commercialize products containing the sweet protein.FinanzNachrichten.deAmai Proteins' sweelin Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage ProductsAmai Proteins announced on Aug. 31, 2026 that Israel's Ministry of Health approved sweelin, a precision-fermented monellin-based sweet protein, as a novel food ingredient for over 25 food and beverage categories. The company says sweelin is on average 3,000 times sweeter than sugar and enables up to 70% sugar reduction. Israel was the third market to approve sweelin in under six months, following US FDA GRAS and Singapore SFA clearance.foodnavigator.comPrecision fermentation reshapes how sweetness is madeOobli, Amai Proteins, and MycoTechnology use precision fermentation to produce sweet proteins that are 1,000-5,000 times sweeter than sugar. These proteins can reduce sugar by 70-90% in some applications, though scaling remains a challenge. The companies see potential for complete sugar replacement as production scales.foodnavigator-usa.comPrecision fermentation reshapes how sweetness is madeThree food technology companies — Oobli, Amai Proteins, and MycoTechnology — are leveraging precision fermentation to develop sweet proteins that decouple sweetness from sugar, offering tailored, protein-based systems as an alternative to traditional sweeteners. Amai Proteins recently secured regulatory approval in Singapore, following an earlier approval in the United States, marking progress in the global commercialization of sweet proteins. The article positions this approach as part of a broader industry shift away from single-ingredient sugar replacements toward redesigning the fundamental mechanisms of sweetness delivery.nutritioninsight.comAmai Protein’s sweet protein sweelin does not impact blood glucose, insulin or GLP-1Amai Protein completed the world's first human clinical trial on its sweet protein sweelin, confirming it has no impact on blood glucose, insulin, or GLP-1 levels. The metabolically neutral results strengthen the commercial credibility of the ingredient, which recently received FDA approval in the US and regulatory clearance in Singapore. Amai Protein intends to use these findings to accelerate product trials and advance commercial discussions with food and beverage manufacturers.PR Newswiresweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose SafetyAmai Proteins announced that the world's first human clinical trial on the metabolic effects of its sweet protein sweelin® has been published in Food Chemistry journal, confirming that sweelin® does not affect blood glucose, insulin, or GLP-1 levels compared to stevia and dextrose in healthy adults. The double-blind, randomized, crossover study, conducted at Tel Aviv Sourasky Medical Center, provides independent scientific validation supporting sweelin®'s safety profile and metabolically neutral characteristics. The publication milestone strengthens commercial credibility and accelerates product trials and commercial discussions with U.S. food and beverage customers, building on the product's prior FDA GRAS approval and Singapore Food Agency clearance.